Waters to Power IMU Biosciences’ AI Platform Measuring Over 100M Immune Data Points
WAT•Waters Corporation will supply BD FACSDiscover and BD Rhapsody instruments to IMU Biosciences, enabling its AI-powered HD Immunology platform to measure over 100 million data points from a single blood sample. The collaboration aims to expand IMU’s immune dataset through large-scale studies and establish a universal standard for immune profiling.
1. Partnership Overview
Waters Corporation and IMU Biosciences have formed a strategic partnership integrating Waters's advanced flow cytometry and single-cell platforms with IMU’s AI-driven HD Immunology platform.
2. Technology Integration
Waters will provide BD FACSDiscover Cell Analyzers, BD Rhapsody Instruments, and BD OMICS-One reagents and panels to support IMU’s proprietary analytics that delivers over 100 million data points from each blood sample in real time.
3. Impact on Immune Profiling
IMU Biosciences aims to expand its world-leading immune dataset through large-scale studies, setting a universal standard for immune profiling and facilitating deeper population-level insights into cancer and other diseases.
4. Future Research Plans
Both companies plan to pursue additional translational research for novel biomarker discovery, using the integrated system to enable clinical applications in flow cytometry and precision medicine.
